SAINT-CLOUD, France, June 17, 2024 /PRNewswire/ -- Ethypharm has entered into an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to acquire the selective antithrombin agent, Argatroban monohydrate (Argatra®, Arganova®, Novastan®, Exembol®), in Europe
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
Ethypharm ready to bring to patients world-leading digital therapies
SAINT-CLOUD, France, June 13, 2023 /PRNewswire/ -- Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Xavier LASSERRE as Chief Commercial Officer (CCO), effective June 12, 2023.
EDMONTON, AB, May 30, 2023 /PRNewswire/ - Aurora Europe GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), and Ethypharm are pleased to announce that they have once again been selected by the French General Directorate of Health (DGS) as exclusive suppliers of dried medical cannabis flower until the end of the French trial period. The trial has recently been extended until March 2024.
SAINT-CLOUD, France, Jan. 31, 2023 /PRNewswire/ -- The Ethypharm Group appoints Bruno Ultra BARCELOS as Managing Director of its UK subsidiary.
Denis DELVAL, Doctor of Pharmacy, graduate of ESSEC and INSEAD, has an impressive range of experience in the pharmaceutical industry where he has spent his entire career in France and internationally in large and medium-sized groups (Bayer, Fournier Pharma, ALK, LFB).
Ethypharm is sad to announce the death Bertrand DELUARD, President &CEO
Ethypharm is the first European pharma laboratory to be awarded the LUCIE 26000 label
Ethypharm has obtained marketing authorisations for the first IR orodispersible tab of morphine